I agree that this site is using cookies. You can find further informations here.
X
Réa, Delphine
237  results:
Search for persons X
?
1

Asciminib monotherapy in patients with chronic-phase chroni..:

Cortes, Jorge E. ; Sasaki, Koji ; Kim, Dong-Wook...
Leukemia.  38 (2024)  7 - p. 1522-1533 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloi..:

Rea, Delphine ; Fodil, Sofiane ; Lengline, Etienne..
Current Hematologic Malignancy Reports.  19 (2024)  3 - p. 104-110 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Dose modification dynamics of ponatinib in patients with ch..:

Jabbour, Elias ; Apperley, Jane ; Cortes, Jorge...
Leukemia.  38 (2024)  3 - p. 475-481 , 2024
Link: https://doi.org/10.1038/..
 
?
4

Optimisation du bosutinib dans la leucémie myéloïde chroniq..:

Rea, Delphine ; Cayssials, Emilie ; Charbonnier, Aude...
Bulletin du Cancer.  111 (2024)  1 - p. 87-96 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Kinetics of molecular recurrence after tyrosine kinase inhi..:

Alcazer, Vincent ; Morisset, Stéphane ; Rea, Delphine...
British Journal of Haematology.  204 (2024)  4 - p. 1536-1539 , 2024
Link: https://doi.org/10.1111/..
 
?
6

Chronic myeloid leukemia diagnosed in pregnancy: management..:

Chelysheva, Ekaterina ; Apperley, Jane ; Turkina, Anna...
Leukemia.  38 (2024)  4 - p. 788-795 , 2024
Link: https://doi.org/10.1038/..
 
?
7

Asciminib monotherapy in patients with CML-CP without BCR::..:

Mauro, Michael J. ; Hughes, Timothy P. ; Kim, Dong-Wook...
Leukemia.  37 (2023)  5 - p. 1048-1059 , 2023
Link: https://doi.org/10.1038/..
 
?
8

POSTER: CML-310 Early Cytogenetic or Molecular Landmark Res..:

Müller, Martin C. ; Cortes, Jorge ; Chuah, Charles...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S175 , 2023
Link: https://doi.org/10.1016/..
 
?
9

CML-398 Responses With Asciminib Continue to Deepen Over Ti..:

Mauro, Michael ; Hochhaus, Andreas ; Hughes, Timothy...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S340 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Health care resource utilization in 3L + patients with chro..:

Cortes, Jorge E. ; Rea, Delphine ; Mauro, Michael J....
Journal of Medical Economics.  26 (2023)  1 - p. 915-923 , 2023
Link: https://doi.org/10.1080/..
 
?
11

First-line second generation tyrosine kinase inhibitors in ..:

Balsat, Marie ; Alcazer, Vincent ; Etienne, Gabriel...
Leukemia Research.  130 (2023)  - p. 107308 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Asciminib vs bosutinib in chronic-phase chronic myeloid leu..:

Hochhaus, Andreas ; Réa, Delphine ; Boquimpani, Carla...
Leukemia.  37 (2023)  3 - p. 617-626 , 2023
Link: https://doi.org/10.1038/..
 
?
13

Treatment‐free remission after dasatinib in patients with c..:

Shah, Neil P. ; García‐Gutiérrez, Valentín ; Jiménez‐Velasco, Antonio...
British Journal of Haematology.  202 (2023)  5 - p. 942-952 , 2023
Link: https://doi.org/10.1111/..
 
?
14

P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO P..:

Müller, Martin C. ; Cortes, Jorge ; Chuah, Charles...
HemaSphere.  7 (2023)  S3 - p. e88427a9 , 2023
Link: https://doi.org/10.1097/..
 
?
15

Efficacy and safety of nilotinib in chronic myeloid leukaem..:

Dulucq, Stéphanie ; Rigal‐Huguet, Françoise ; Nicolini, Franck E....
British Journal of Haematology.  201 (2023)  6 - p. 1116-1124 , 2023
Link: https://doi.org/10.1111/..
 
1-15